APA (7th ed.) Citation

S, S., Y, D., J, R., X, H., J, B., T, W., . . . W, T. (2026). Structurally-optimised HPV16 E7/E6 mRNA-LPP mediates dose-sparing efficacy via tumour microenvironment reprogramming. Molecular biomedicine, 7(1), . https://doi.org/10.1186/s43556-026-00412-9

Chicago Style (17th ed.) Citation

S, Sun, et al. "Structurally-optimised HPV16 E7/E6 MRNA-LPP Mediates Dose-sparing Efficacy via Tumour Microenvironment Reprogramming." Molecular Biomedicine 7, no. 1 (2026). https://doi.org/10.1186/s43556-026-00412-9.

MLA (9th ed.) Citation

S, Sun, et al. "Structurally-optimised HPV16 E7/E6 MRNA-LPP Mediates Dose-sparing Efficacy via Tumour Microenvironment Reprogramming." Molecular Biomedicine, vol. 7, no. 1, 2026, https://doi.org/10.1186/s43556-026-00412-9.